Clene Inc. Common Stock(CLNN)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Snapshot
$4.78
After hours $5.57 +0.00%
52-Week Range
$3.25 – $13.50
YTD
-17.16%
IV Rank (30D)
0
Straddle Price
$4.83
P/C Vol Ratio
0.32
Market Cap
$0.1B
Fair Value

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 0.5% and dividend payments are stable.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.47%
Beta vs SPY1.00
Cost of Equity (CAPM)9.47%
WACC8.43%
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)-10.0%
DCF Horizon10 years explicit + fade
Free Cash Flow (TTM)$-0.0B
Return on Equity (TTM)177.9%
Book / Price-34.2%
Gross Margin (TTM)82.8%
FCF Margin (TTM)-13509.0%
Quality Score2/6 — normal (10y DCF)
SMA 50$6.26 (Market Anchor value)
SMA 20 / Bollinger Mid$6.41
Bollinger Width / SMA20489.6% (drives anchor stability)
Net Debt$0.0B
Market Cap$0B
Blended Fair Value
Current Price
$5.33
Deviation
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0%
Peer EV/EBITDA n/a 0%
Peer P/B n/a 0%
Peer P/S n/a 0%
Market Anchor (SMA50) $6.26 0% stability 0% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-06-09 · updated 2026-06-09 09:30:52.280000
Info
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834)
Exchange
XNAS
Market Cap
$0.1B

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Price History
Seasonality
MonthAvg ReturnYears of Data
Jan +2.17% 6
Feb +16.34% 6
Mar -2.25% 6
Apr -9.36% 6
May -1.25% 6
Jun +1.94% 6
Jul -10.65% 5
Aug +9.03% 5
Sep -11.36% 5
Oct +11.75% 5
Nov -6.06% 5
Dec -15.67% 6
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $6.36
SMA 50: $6.28
SMA 200: $6.55
Current: $5.57
EMA 12: $5.96
EMA 26: $6.21
MACD: -0.2459 | Signal: -0.1554
BEARISH
ADX (14): 18.18
RANGE
+DI: 13.46
−DI: 23.79
Momentum Oscillators
RSI (14): 40.22
NEUTRAL
Stoch %K: 8.44
Stoch %D: 8.68
Williams %R: -80.95
Volume & Volatility
BB Upper: $7.43
BB Lower: $5.29
NEUTRAL
OBV: 20,588,660
Vol SMA 20: 144,452
Vol ROC: -1.69%
ATR: $0.53
True Range: $0.46
HV 20: 66.7%
HV 30: 124.9%
HV 60: 108.6%

Data Summary
Data Points: 500
Last Updated: 2026-06-09T21:15:14.973000
Date Range: 2024-06-11T00:00:00 – 2026-06-09T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
Options Activity
IV Rank (30D)
0
IV Rank (7D)
0
Avg IV
0.0%
Straddle (30D)
$4.83
Straddle (7D)
$4.83
P/C Volume
0.32
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Volatility Surface

Enter a ticker to render the implied volatility surface.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
1.89
Correlation (SPY)
20.8%
0.04
Ann. Volatility
110.2%
SPY Volatility
12.1%

High volatility - stock moves more than market

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-03-31
Diluted shares outstanding: 10,327,846 (as of 2026-03-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

27 filers2,059,589 shares$10.38M value19.94% of float
# Filer Shares Value % of Total % of Float Period
1 Boxer Capital Management, LLC 477,515 $2.35M 22.68% 4.62% 2026-03-31
2 SymBiosis Capital Partners, LLC 431,094 $2.13M 20.47% 4.17% 2026-03-31
3 SCOGGIN MANAGEMENT LP 300,000 $1.48M 14.25% 2.90% 2026-03-31
4 VANGUARD GROUP INC Custodian 222,909 $1.31M 12.60% 2.16% 2025-12-31
5 Ensign Peak Advisors, Inc 257,872 $1.27M 12.25% 2.50% 2026-03-31
6 GEODE CAPITAL MANAGEMENT, LLC Custodian 95,874 $473.04K 4.56% 0.93% 2026-03-31
7 Lunt Capital Management, Inc. 52,260 $257.64K 2.48% 0.51% 2026-03-31
8 PEAK6 LLC 50,012 $246.56K 2.37% 0.48% 2026-03-31
9 PARSONS CAPITAL MANAGEMENT INC/RI 37,243 $183.61K 1.77% 0.36% 2026-03-31
10 BlackRock, Inc. Custodian 33,799 $166.63K 1.60% 0.33% 2026-03-31
11 STATE STREET CORP 29,801 $146.92K 1.42% 0.29% 2026-03-31
12 MORGAN STANLEY Custodian 20,429 $119.92K 1.16% 0.20% 2025-12-31
13 NORTHERN TRUST CORP Custodian 16,143 $79.58K 0.77% 0.16% 2026-03-31
14 PENN DAVIS MCFARLAND INC 11,000 $54.23K 0.52% 0.11% 2026-03-31
15 WELLS FARGO & COMPANY/MN Custodian 5,927 $29.22K 0.28% 0.06% 2026-03-31
16 JONES FINANCIAL COMPANIES LLLP Custodian 5,000 $23.55K 0.23% 0.05% 2026-03-31
17 UBS Group AG Custodian 3,977 $19.61K 0.19% 0.04% 2026-03-31
18 PNC FINANCIAL SERVICES GROUP, INC. Custodian 2,735 $13.48K 0.13% 0.03% 2026-03-31
19 Atlantic Private Wealth, LLC 2,205 $10.87K 0.10% 0.02% 2026-03-31
20 OSAIC HOLDINGS, INC. Custodian 1,926 $9.49K 0.09% 0.02% 2026-03-31
21 GROUP ONE TRADING LLC Custodian 686 $3.38K 0.03% <0.01% 2026-03-31
22 Arax Advisory Partners 570 $2.81K 0.03% <0.01% 2026-03-31
23 Tower Research Capital LLC (TRC) Custodian 444 $2.19K 0.02% <0.01% 2026-03-31
24 MAI Capital Management Custodian 100 $493 <0.01% <0.01% 2026-03-31
25 SBI Securities Co., Ltd. 25 $123 <0.01% <0.01% 2026-03-31
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

P/B Ratio-3.6
P/S Ratio508.3
EV/EBITDA-4.1
TTM Revenue$0.0B
TTM Net Income$-0.0B
TTM EPS$-3.2
ROE177.9%
Debt/Equity-0.97